Tags: Drug.

Sibrafiban (Ro 48-3657 proposed brand name Xubix) is the double prodrug of Ro-44-3888 which is a platelet aggregation inhibitor. It was being developed for secondary prevention of arterial thrombosis following unstable angina pectoris and acute myocardial infarction (MI).

Sibrafiban_structure.svg
FDA UNII code
YUE443B0NF
IUPAC name
[Z]-(S)-[​[1-[2-[​[4-(amino-hydroxyiminomethyl)-benzoyl]amino]-1-oxopropyl]-4-piperidinyl]oxyl]-acetic ethyl ester
PubChem
5491394

Loading...

This page contains content from the copyrighted Wikipedia article "Sibrafiban"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.